(11540447), S. N., (9201761), D. M. O., (527968), C. C., (5004785), A. P., (11692038), K. F., (582056), M. K., . . . (11540462), P. M. K. (2023). Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease.
Chicago Style (17th ed.) Citation(11540447), Satra Nim, et al. Disrupting the α-synuclein-ESCRT Interaction with a Peptide Inhibitor Mitigates Neurodegeneration in Preclinical Models of Parkinson’s Disease. 2023.
MLA (9th ed.) Citation(11540447), Satra Nim, et al. Disrupting the α-synuclein-ESCRT Interaction with a Peptide Inhibitor Mitigates Neurodegeneration in Preclinical Models of Parkinson’s Disease. 2023.
Warning: These citations may not always be 100% accurate.